Diagnosis of latent tuberculosis infection is associated with reduced HIV viral load and lower risk for opportunistic infections in people living with HIV

Bacterial InfectionsHIV / AIDS

Safety and Efficacy of Rifampin or Isoniazid Among People with Mycobacterium tuberculosis Infection and Living with HIV or Other Health Conditions: Post-Hoc Analysis of Two Randomized Trials

Clin Infect Dis.

Campbell JR, Al-Jahdali H, Bah B, Belo M, Cook VJ, Long R, Schwartzman K, Trajman A, Menzies D

doi: 10.1093/cid/ciaa1169.

HIV / AIDS

Primary health care: an opportunity for early identification of people living with undiagnosed HIV infection

HIV Med.

Martin-Iguacel R, Pedersen C, Omland LH, Søndergaard J, Jensen J, Llibre JM, Johansen IS, Obel N, Rasmussen LD

doi: 10.1111/hiv.12735.

HIV / AIDS

Cancer risk following lymphoid malignancies among HIV-infected people

AIDS.

Mahale P, Ugoji C, Engels EA, Shiels MS, Peprah S, Morton LM

doi: 10.1097/QAD.0000000000002528.

HIV / AIDS

Immune deficiency is a risk factor for severe COVID-19 in people living with HIV

HIV Med

Hoffmann C, Casado JL, Härter G, Vizcarra P, Moreno A, Cattaneo D, Meraviglia P, Spinner CD, Schabaz F, Grunwald S, Gervasoni C

doi: 10.1111/hiv.13037

HIV / AIDS

2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0

HIV Med.

Ryom L, Cotter A, De Miguel R, Béguelin C, Podlekareva D, Arribas JR, Marzolini C, Mallon P, Rauch A, Kirk O, Molina JM, Guaraldi G, Winston A, Bhagani S, Cinque P, Kowalska JD, Collins S, Battegay M, EACS Governing Board.

doi: 10.1111/hiv.12878.

Chronic PainComplex Regional Pain Syndrome (CRPS)

Coronary Artery Disease-associated and Longevity-associated Polygenic Risk Scores for Prediction of Coronary Artery Disease Events in Persons Living with HIV: The Swiss HIV Cohort Study

Clin Infect Dis

Schoepf IC, Thorball CW, Ledergerber B, Engel T, Raffenberg M, Kootstra NA, Reiss P, Hasse B, Marzolini C, Thurnheer C, Seneghini M, Bernasconi E, Cavassini M, Buvelot H, Kouyos R, Günthard HF, Fellay J, Tarr PE, , for the Swiss HIV Cohort Study.

doi: 10.1093/cid/ciab521

Bacterial Infections

Isoniazid-Rifapentine for Latent Tuberculosis Infection: A Systematic Review and Meta-analysis

Am J Prev Med.

Njie GJ, Morris SB, Woodruff RY, Moro RN, Vernon AA, Borisov AS

doi: 10.1016/j.amepre.

HIV / AIDS

Validation of the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) chronic kidney disease risk score in HIV-infected patients in the USA

HIV Med.

Mills AM, Schulman KL, Fusco JS, Brunet L, Hsu R, Beyer A, Prajapati G, Mounzer K, Fusco GP

doi: 10.1111/hiv.12826.

Viral Infections, Non-HIV

Time to detection of hepatitis C virus infection with the Xpert HCV Viral Load Fingerstick Point-of-Care Assay: Facilitating a more rapid time to diagnosis

J Infect Dis.

Grebely J, Catlett B, Jayasinghe I, Valerio H, Hajarizadeh B, Verich A, Cunningham P, Martinello M, Tillakeratne S, Silk D, Dore GJ, Applegate TL

doi: 10.1093/infdis/jiaa037.

Related content

Safety and Efficacy of Rifampin or Isoniazid Among People with Mycobacterium tuberculosis Infection and Living with HIV or Other Health Conditions: Post-Hoc Analysis of Two Randomized Trials

Primary health care: an opportunity for early identification of people living with undiagnosed HIV infection

Cancer risk following lymphoid malignancies among HIV-infected people

Immune deficiency is a risk factor for severe COVID-19 in people living with HIV

2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0

Coronary Artery Disease-associated and Longevity-associated Polygenic Risk Scores for Prediction of Coronary Artery Disease Events in Persons Living with HIV: The Swiss HIV Cohort Study

Isoniazid-Rifapentine for Latent Tuberculosis Infection: A Systematic Review and Meta-analysis

Validation of the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) chronic kidney disease risk score in HIV-infected patients in the USA

Time to detection of hepatitis C virus infection with the Xpert HCV Viral Load Fingerstick Point-of-Care Assay: Facilitating a more rapid time to diagnosis